https://mc06.manuscriptcentral.com/bcb-pubs To verify the Lf role in Pseudomonas aeruginosa lung infection, here we evaluated the efficacy of aerosolized bovine Lf (bLf) in mouse models of P. aeruginosa acute and chronic lung infections.
it exerts the bacteriostatic activity related to its ability in sequestering iron required for microbial survival and growth, and, the bactericidal, anti-adhesive and anti-invasive activities related to its binding to bacterial or host cell surface components, independently from its iron-binding function (Valenti et al. 2004; Valenti and Antonini 2005) . Noteworthy, Lf exerts anti-inflammatory activity, contributing to mucosal protection from inflammation-related damage (Berlutti et al. 2006; Valenti et al. 2011; Legrand 2012; Latorre et al. 2012 ). This property may be relevant in inflammatory diseases as cystic fibrosis (CF) airways infections in which the exaggerate inflammation that can precede the bacterial infection (Dakin et al. 2002; Verhaeghe et al. 2007) negatively correlates with lung functionality, cell damage, and disease severity sustained by
Pseudomonas aeruginosa (Reid et al. 2007; O'Sullivan and Flume 2009; Cohen and Prince 2012; Smith et al. 2014) . Despite to the improvement of infection therapy based on aerosolized antibiotics (Waters and Smyth 2015) , chronic Pseudomonas aeruginosa infections remain very difficult to treat (Gibson et al. 2003; Vidya et al. 2015) . Therefore, there is the need to develop new therapeutic strategies not based on the use of antibiotics but with pleiotropic agents to treat
P. aeruginosa lung infection.
Lf that is one of the most abundant factors of natural immunity in airway secretions (Travis et al. 1999 ), could represent a good candidate for its antibacterial and anti-inflammatory properties.
Interestingly, bovine milk derivative-Lf (bLf) induced a dramatic decrease of pro-inflammatory cytokines in in vitro CF human airway epithelium infected with P. aeruginosa (Frioni et al. 2014 aeruginosa strains were grown in tryptic soy broth (TSB) (Becton Dickinson, Sparks, MD, USA) to reach the exponential phase. Next, the bacteria were pelleted by centrifugation (2700 g, 15 min, 4°C) and washed twice with sterile PBS before the infection.
Lactoferrin
Highly purified bovine milk derivative Lf (bLf) was kindly provided by Morinaga Milk Industries
Co., Ltd. (Tokyo, Japan). The purity and iron saturation of bLf were checked (Frioni et al. 2014 ). BLfiron saturation was of 15%. LPS contamination of bLf was estimated by Limulus Amebocyte assay (LAL Pyrochrome kit, PBI International, Italy) and was equal to 0.5±0.04 ng/mg of bLf. Before use, bLf saline solutions were sterilized by 0.2 µm filter (Millipore Corp., Bedford, Mass.).
Ethic Statement
Animal studies were conducted according to protocols approved by San Raffaele Scientific (Facchini et al. 2014; Bianconi et al. 2015) . P. aeruginosa strains were implanted via the cannula into the lung with both lobes inoculated.
For acute and chronic lung infection, a total of 19 and 33 mice, respectively, were randomly assigned to the different treatment groups. Treatments with aerosolized bLf or saline were started 5 min after infection. Mice were treated with 50 µl of freshly prepared solutions containing 100 µg 
Lung homogenization and cytokine analysis
Lungs were removed and homogenized in 2 ml PBS containing protease inhibitors. Samples were serially diluted 1:10 in PBS and plated for CFU counts. Lung homogenates were then centrifuged at 16000 g for 30 min at 4°C and the supernatants were stored at -80°C for cytokine and chemokine analysis. After quantification of total protein content with Bradford's assay (Bio-RAD, California 94547, USA), cytokine levels in supernatants were analyzed using the Bio-Plex 
Statistical analysis
Results were derived from at least three independent experiments and reported as mean values ± standard deviations. Two-way ANOVA with Bonferroni's multiple comparison test was used to compare change in body weight. For CFUs, cells and cytokines/chemokines levels analysis, One-way ANOVA followed by Bonferroni's analysis was used to compare three experimental groups and Mann-Whitney U test to compare two experimental groups. The analyses were performed using Prism (GraphPad). Tests are considered statistically significant when the significance P was ≤0.05.
D r a f t

Results
Effect of aerosolized bLf on P. aeruginosa CFUs in lung homogenates and BALs
To evaluate the antibacterial effect of aerosolized bLf, P. aeruginosa counts were performed in lung homogenates and BALs. A partial reduction of P. aeruginosa CFUs in bLf-respect to salinetreated mice was observed in both acute and chronic lung infections even if the differences did not reach statistical significance. Concerning acute infection, higher reduction of P. aeruginosa Similar results were yielded in chronic infections where P. aeruginosa CFUs were lower in bLfthan saline-treated mice even if at not significant values ( Figure 1, panel B) . However, the clearance of infection was observed in three out of 17 (18%) bLf-treated mice while no bacterial clearance was observed in saline-treated mice.
Effect of aerosolized bLf on inflammatory response
To establish the activity of aerosolized bLf on inflammatory response, the total and differential counts of leukocytes in BALs as well as the cytokine/chemokine production in lung homogenates were examined. Concerning the counts of leukocytes, in acute infection a significant reduction of total cells in bLf-treated respect to control mice was showed ( Cytokine/chemokine production on supernatants of lung homogenates of mice affected by acute and chronic infections was examined. Some cytokines were not expressed at all or expressed at very low levels and precisely: IL-2, IL-3, IL-5, IL-9, and GM-CSF. A total of 18 cytokines were expressed and as general rule, the levels of expressed cytokines were lower in chronic than in acute infection (Tables 1; Figure 3 ). The bLf treatments was ineffective on the levels of 10 cytokines (Table 1 ) and the decreased the expression of 8 cytokines (Figure 3 ).
In particular, in acute infection, the treatment with the 100 µg of bLf was ineffective on cytokine levels, while the dose of 200 µg bLf induced a significant decrease of 7 cytokines (IL-1α, KC, G-CSF, MIP-1α, IL-6, IL-12(p40), and IL-12(p70) ) (Figure 3 ).
In chronic infection, the treatment with 200 µg of aerosolized bLf decreased the expression of several cytokines. In particular, IL-1α, IL-1β, and G-CSF levels were diminished at significant level, while those of KC, MIP-1α, IL-12(p40), and IL-12(p70) were reduced at not significant level ( Figure   3 ). IL-6 was not detected in both bLf-and saline-treated mice (Figure 3) .
Effect of aerosolized bLf on body weight of mice affected by P. aeruginosa chronic lung infection
Since the bacterial infection affect mouse health, body weight loss was checked twice a day as 
Discussion
In this paper, we evaluated the role of aerosolized bLf in mouse models of P. aeruginosa lung infections. This bacterium is a serious pathogen for CF patients (Lenney 2015) and causes infections difficult to eradicate (Gibson et al. 2003; Vidya et al. 2015) . During the infection development in CF patients, P. aeruginosa switches from an acute virulent pathogen, characteristic of early infections, to a CF-adapted pathogen, typical of chronic infection stages (Gomez and Prince 2007; Bragonzi et al. 2009; Rau et al. 2010; Hogardt and Heesemann 2013) .
Here, we employed two P. aeruginosa strains to induce acute and chronic infections. PAO1 was used to induce acute infections as it shows the characteristics of a strain isolated in CF acute lung infection as high rate of virulence and mortality in infected mice (Bianconi et al. 2015) ; MDR-RP73 strain, isolated from chronic lung infection in a CF patient (Jeukens et al. 2013) , was employed in chronic infection where this MDR-RP73 strain was embedded in agar beads to maintain the lung infection for several days thus avoiding spontaneous bacterial clearance (Facchini et al. 2014 ).
The infected mice were differently treated with aerosolized bLf according to the type of infection (i.e: acute or chronic). The use of bLf is justified by the fact that bLf is generally recognized as a safe substance by Food and Drug Administration (USA) and available in large quantities. Therefore, bLf is utilized in the majority of the in vitro studies as well as in clinical trials (see the ClinicalTrials.Gov site https://clinicaltrials.gov/ct2/home) to identify putative applications (Manzoni et al. 2014; Paesano et al. 2010 Paesano et al. , 2012 Paesano et al. , 2014 .
In acute lung infection, the mice received only one treatment with aerosolized bLf to evaluate the early response to infection while in chronic infection the infected mice were treated for 6 days to evaluate the late response to chronic infection.
The treatment with aerosolized bLf decreased the bacterial load of about 0.5 logs of CFUs in both acute and chronic infections respect to control (Figure 1) Kamiya et al. 2012) . Anyway, it is interesting to underline that in chronic infection 18% of the bLf-treated mice cleared the infection as no P.
aeruginosa was found in both BALs and lung homogenates.
The most relevant effect of aerosolized bLf was observed in inflammatory response. Firstly, the total and differential leukocyte counts were determined in BALs. The aerosol administration of bLf reduced significantly the leukocyte counts in both acute and chronic infection respect to controls.
Interestingly, in acute infection the significant reduction of leukocytes was observed with both the doses of aerosolized bLf (100 and 200 µg) (Figure 2 , Panel A). When the differential counts in both acute and chronic infections were evaluated, the decrease involved only the neutrophil populations, while the macrophages were not affected (Figure 2) . Firstly, the mouse models used in this study were proven useful to test novel therapies targeted at reducing infection and/or inflammation (Bragonzi 2010; Cigana et al. 2016) .
At the best of our knowledge, this is the first time that the influence of aerosolized bLf on neutrophil recruitments in lung infection is shown.
The cytokine/chemokine production was higher in acute than chronic infection (Figures 3; Tables 1). These results may be due to the different P. aeruginosa strains: PAO1 is able to induce a fast and high inflammatory responses (Tayabali et al. 2015) while the MDR-RP73 induces a low inflammatory response (Di Lorenzo et al. 2015) .
The aerosolized bLf was ineffective in modulating some cytokines (Table 1) The reduced neutrophil recruitment mediated by bLf treatment is likely related to the decrease of KC as well as of G-CSF and MIP-1α, key molecules involved in neutrophil development and function (Lieschke et al. 1994; Natori et al. 2002; Frioni et al. 2014; Christensen et al. 2016 ).
Interestingly, the bLf treatment did not annul the KC production as already shown in in vitro models for IL-8 (Berlutti et al. 2006; Valenti et al. 2011; Frioni et al. 2014) . These data suggest a protective activity of bLf in reducing the neutrophil-mediated damage.
Concerning IL-6, its level was significantly lowered by bLf treatment in acute infection while it was not produced in chronic infection confirming its peculiar role in acute phase response ( Figure   3 ) (Scheller et al. 2011) . This interleukin together with IL-12(p40) and IL-12(p70) may play a relevant role in inflammatory response. As matter of the fact, both IL-6 and IL-12 productions are Taken on the whole, the present data confirm the potent anti-inflammatory activity of bLf also in the context of respiratory infections. Even if the anti-inflammatory activity of aerosolized bLf has been described in the past (Elrod et al. 1997; Chen et al. 2014) , this is the first time that the anti-inflammatory function of aerosolized bLf is shown in mice affected by acute and chronic P.
aeruginosa lung infections. Significantly, the aerosolized bLf resulted in the improvement of well-D r a f t 14 being and health of infected mice since in chronic infection the bLf-treated mice recovered the body weight more rapidly and at higher extent than the control mice (Figure 4 ).
In conclusion, the aerosol administration of bLf had a multiple protective effect on infected mice: decreased P. aeruginosa load; decreased neutrophil recruitment as well as some proinflammatory cytokines/chemokines, and ameliorated the health of the infected mice. The exact mechanism of action of bLf is to be deepened and the reported data must be confirmed in CF mice. 
